With regard to voluntary compliance undertakings (VCU) and board orders by the Patented Medicines Prices Review Board (PMPRB), since January 1, 2016: (a) what is the total amount of money that has been made payable from pharmaceutical companies to her Majesty in right of Canada through voluntary compliance undertakings and board orders, both sum total, broken down by (i) company, (ii) product, (iii) summary of guideline application, (iv) amount charged, (v) date; (b) how is the money processed by the PMPRB; (c) how much of the intake from VCUs and board orders are counted as revenue for the PMPRB; (d) how much of the intake from VCUs and board orders are considered revenue for Health Canada; (e) as the Public Accounts lists capital inflow from VCUs as revenue, what has the PMPRB done with the inflow; and (f) who decides the distribution of the capital inflow from VCUs?
In the House of Commons on June 16th, 2021. See this statement in context.